Journal of Radiology
Open Access

Conference Series extends its welcome to the conference 21^st World Submit on Oncology and Radiology during October 19-20, 2019 Austria, Vienna with a theme “New Challenges and Explore the Prevention of Oncology”.Conference Series llc LTD Organizes 1000+ Conferences Every Year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 700+ Open access journals which contains over 100000 eminent personalities, reputed scientists as editorial board members. Oncology 2020, Conference will focus on educational research directed toward its impact on clinical outcomes, through oral and poster presentations, educational workshop sessions, and influential plenarypresentations. Oncology 2020 is a perfect platform to find out how cancer and Oncology research innovations helpful to the Medical, Health and human society. Conference will mainly focus on the trending topics during presentations of the twoday event, which reflect current education, research, developments and innovations internationally in the field of cancer, oncology and medical sectors.

Oncology market research highlights that the industry is currently undergoing an interesting phase where cases of cancer are rising globally, but death rates are at a decline. Due to these rising incidences, we forecast the oncology drugs market to witness growth over the next few years. The chemotherapy-induced nausea and vomiting drugs market, in particular, is offering opportunities for market players as its market size is expanding owing to the growing preference of chemotherapy in the developing countries across the globe.

The global radiation oncology market size was valued at USD 5.7 billion in 2016 and is expected to expand at a CAGR of 6.5% over the forecast period. Rising adoption of radiotherapy, rapid technological advancements, high prevalence of cancer, and increasing healthcare expenditure are the key contributing factors for lucrative market growth.

Radiotherapy is effective treatment for different types of cancer. It can also be used in combination with operation, chemotherapy, or immunotherapy. Rising acceptance of this therapy is boosting the market growth at a significant rate. Radiotherapy can be used at three levels including primary cancer treatment, adjuvant therapy after chemotherapy, and as palliative therapy to shrink the size of tumour and to suppress the symptoms.

High prevalence of cancer is expected to fuel demand for radiotherapy over the forecast period. According to the World Health Organization (WHO), 14.0 million new cases of cancer and 8.2 million cancer-related deaths were registered in 2012. This number is anticipated to increase by about 70.0% over the next two decades. Cancer is affecting more than 14.0 million people each year. Technological advancements and integration of radiotherapy with other imaging methods resulted in efficient treatment option. Emergence of techniques such as Three-Dimensional Conformal Radiotherapy (3D-CRT), Intensity Modulated Radiation Therapy (IMRT), and Image-Guided and Stereotactic Radiation Therapy has opened effective treatment options with minimal adverse effect. For instance, dry mouth is the most common adverse effect of head and neck cancer treatment. However, 3D-CRT limits the damage to the salivary gland, which causes dry mouth.

Ileana Kipps
Program Manager | Medical Imaging 2020
47 Churchfield Road | London, W3 6AY, United Kingdom
Phone: +448000148923
E-mail: medicalimaging@scientistviewpoint.com